Gene: RAC3
Official Full Name: Rac family small GTPase 3provided by HGNC
Gene Summary: The protein encoded by this gene is a GTPase which belongs to the RAS superfamily of small GTP-binding proteins. Members of this superfamily appear to regulate a diverse array of cellular events, including the control of cell growth, cytoskeletal reorganization, and the activation of protein kinases. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO08954 | RAC3 Knockout cell line (HeLa) | Human | RAC3 | 1:3~1:6 | Negative | Online Inquiry |
KO08955 | RAC3 Knockout cell line (HCT 116) | Human | RAC3 | 1:2~1:4 | Negative | Online Inquiry |
KO08956 | RAC3 Knockout cell line (HEK293) | Human | RAC3 | 1:3~1:6 | Negative | Online Inquiry |
RAC3 Gene Knockout Cell Lines represent a refined tool in molecular biology designed to facilitate the study of gene function and regulation through the targeted disruption of the RAC3 gene. These established cell lines are derived from mammalian systems where the RAC3 gene, an important member of the Rho family of GTPases, is systematically knocked out. This genetic modification enables researchers to observe and quantify the downstream effects on various cellular processes such as cell signaling, cytoskeletal dynamics, and gene expression profiles.
The key function of RAC3 Gene Knockout Cell Lines lies in their ability to provide insights into cellular mechanisms influenced by the RAC3 protein. By inhibiting RAC3 function, researchers can explore vital pathways that regulate cell adhesion, migration, and proliferation, which are fundamental in understanding cancer biology, neurobiology, and other physiological conditions. The versatility of these cell lines makes them particularly advantageous in research settings focused on the therapeutic targets associated with Rho GTPases.
From a scientific perspective, these cell lines hold significant promise as model systems for investigating the pathophysiological roles of RAC3 in disease contexts. They can be utilized in drug discovery processes, biomarker identification, and basic biological research to dissect signal transduction pathways. Compared to alternatives such as siRNA-mediated knockdown or transient transfection methods, RAC3 Gene Knockout Cell Lines provide a stable and reproducible platform for long-term studies, reducing variability and enhancing experimental rigor.
For researchers and clinicians, the value of RAC3 Gene Knockout Cell Lines lies in their potential to elucidate the complexities of gene functions and interactions in live cellular environments. By adopting these tools, users can significantly advance their understanding of cellular mechanisms and the molecular underpinnings of diseases, ultimately contributing to the development of innovative therapeutic strategies.
Our company prides itself on its commitment to delivering high-quality biological products supported by extensive research and development. With a focus on providing robust solutions for the scientific community, we ensure that our RAC3 Gene Knockout Cell Lines are rigorously tested and optimized for various experimental applications, empowering scientists to achieve impactful results in their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.